Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes

Journal of Hepatology

Volumn 27, Issue 3, 1997, Pages 445-454

  Ikeda, Masanori ^a   Kato, Nobuyuki ^a   Mizutani, Tetsuya ^a   Sugiyama, Kazuo ^a   Tanaka, Katsuaki ^b   Shimotohno, Kunitada ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Cell tropism; Hepatitis C virus; Hyper variable region 1; Phylogenetic tree; Replication system

Indexed keywords

ANALYTIC METHOD; ARTICLE; CELL GROWTH; CELL IMMORTALIZATION; CELL POPULATION; CHRONIC HEPATITIS; DNA SEQUENCE; FIBROBLAST; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LIVER CELL; LYMPHOCYTE; MONONUCLEAR CELL; PATHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0030864521     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80347-9     Document Type: Article

References (60)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
2. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:1989;362-364.
3. Ohkoshi S, Kojima H, Tawaraya H, Miyajima T, Kamimura T, Asakura H, et al. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Jpn J Cancer Res. 81:1990;550-553.
4. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA. 87:1990;6547-6549.
5. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA. 87:1990;9524-9528.
6. Muraiso K, Hijikata M, Ohkoshi S, Cho MJ, Kikuchi M, Kato N, et al. A structural protein of hepatitis C virus expressed in E. coli facilitates accurate detection of hepatitis C virus. Biochem Biophys Res Commun. 172:1990;511-516.
7. M Hijikata, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA. 88:1991;5547-5551.
8. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 14:1991;381-388.
9. Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, et al. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol. 67:1993;4665-4675.
10. Hijikata M, Mizushima H, Tanji Y, Komoda Y, Hirowatari Y, Akagi T, et al. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci USA. 90:1993;10773-10777.
11. Shimotohno K. Hepatitis C virus as a causative agent of hepatocellular carcinoma. Intervirology. 38:1995;162-169.
12. J Bukh, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 15:1995;41-63.
13. Shimizu YK, Purcell RH, Yoshikura H. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc Natl Acad Sci USA. 90:1993;6037-6041.
14. Nakajima N, Hijikata M, Yoshikura M, Shimizu YK. Characterization of long-term cultures of hepatitis C virus. J Virol. 70:1996;3325-3329.
15. Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hyprevariable region 1 of hepatitis C virus can block viral attachment. Virology. 208:1995;653-661.
16. Cribier B, Schmitt C, Bingen A, Kirn A, Keller F. In vitro infection of peripheral blood mononuclear cells by hepatitis C virus. J Gen Virol. 76:1995;2485-2491.
17. Lanford RE, Sureau C, Jacob JR, White R, Fuerst TR. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology. 202:1994;606-614.
18. Kato N, Nakazawa T, Mizutani T, Shimotohno K. Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun. 206:1995;863-869.
19. Mizutani T, kato N, Hirota M, Sugiyama K, Murakami A, Shimotohno K. Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells. Biochem Biophys Res Commun. 212:1995;906-911.
20. Kato N, Ikeda M, Mizutani T, Sugiyama K, Noguchi M, Hirohashi S, et al. Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes. Jpn J Cancer Res. 87:1996;787-792.
21. Mizutani T, Kato N, Saito S, Ikeda M, Sugiyama K, Shimotohno K. Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2. J Virol. 70:1996;7219-7223.
22. Martell M, Esteben JI, Quer J, Genesca J, Weiner A, Esteban R, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol. 66:1992;3225-3229.
23. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun. 175:1991;220-228.
24. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180: 842-8.
25. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Sekiya H, Hijikata M, et al. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus. Biochem Biophys Res Commun. 189:1992;119-127.
26. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami K, Ohba Y, et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology. 197:1993;659-668.
27. Kurosaki M, Enomoto N, Marumo F, Sato C. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology. 18:1993;1293-1299.
28. Sekiya H, Kato N, Ootsuyama Y, Nakazawa T, Yamauchi K, Shimotohno K. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus inthe progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1. Int J Cancer. 57:1994;664-670.
29. Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, et al. Genetic drift in hypervariabl region 1 of the viral genome in persistent hepatitis C virus infection. J Virol. 68:1994;4776-4784.
30. Doorn LE, Capriles I, Maertens G, Deleys R, Murray K, Kos T, et al. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol. 69:1995;773-778.
31. Hijikata M, Mizuno K, Rikihisa T, Shimizu YK, Iwamoto A, Nakajima N, et al. Selective transmission of hepatitis C viris in vivo and in vitro. Arch Virol. 140:1995;1623-1628.
32. Sugiyama K, kato N, Mizutani T, Ikeda M, Tanaka T, Shimotohno K. Genetic analysis of the hepatitis C virus (HCV) genome from HCV-infected human T cells. J Gen Virol. 78:1997;329-336.
33. Enomoto N, Takada A, Nakao t, Date T. Tere are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun. 170:1990;1021-1025.
34. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Mori S, Hijikatta M, et al. Distribution of plural HCV types in Japan. Biochem Biophys Res Commun. 181:1991;279-285.
35. Noguchi M, Hirohashi S. Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient. In vitro Cell Dev Biol Anim. 32:1996;135-137.
36. Okamoto H, Okada S, Sugiyama Y, Kurai K, Iizuka H, Machida Y, et al. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol. 72:1991;2697-2704.
37. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Sequence diversity of hepatitis C viral genomes. Mol Biol Med. 7:1990;495-501.
38. Nakazawa T, Kato N, Ootsuyama Y, Sekiya H, Fujioka T, Shibuya A, et al. Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier. Int J Cancer. 56:1994;204-207.
39. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA. 88:1991;3392-3396.
40. Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, et al. Marked sequence diversity in the putative envelope protein of hepatitis C viruses. Virus Res. 22:1992;107-123.
41. Okamoto H, Kojima M, Okada SI, Yoshizawa H, Iizuka T, Tanaka T, et al. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology. 190:1992;894-899.
42. Saito S, Kato N, Hijikata M, Gunji T, Itabashi M, Kondo M, et al. Comparison of hypervariable regions (HVR1 and HVR2) in positive- and negative-stranded hepatitis C virus RNA in cancerous and noncancerous liver tissue, peripheral blood mononuclear cells, and serum from a patient with hepatocellular carcinoma. Int J Cancer. 67:1996;199-203.
43. Nei M, Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol. 3:1986;418-426.
44. Muller HM, Pfaff E, Goeser T, Kallinowski B, Solbach C, Theilmann L. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol. 74:1993;669-676.
45. Gunji T, Kato N, Hijikata M, Hayashi K, Saitoh S, Shimotohno K. Specific detection of positive and negative stranded hepatitis C viral RNA using chemical RNA modification. Arch Virol. 134:1994;293-302.
46. Lerat H, Berby F, Trabaud MA, Vidalin O, Major M, Trepo C, Inchauspe G. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest. 97:1996;845-851.
47. Ferri C, Monti M, Civita LL, Longombardo G, Greco F, Pasero G, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood. 82:1993;3701-3704.
48. Gabrielli A, Manzin A, Candela M, Caniglia ML, Paolucci S, Danieli MG, et al. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. Clin Exp Immunol. 97:1994;87-93.
49. Luppi M, Ferrari MG, Bonaccorsio G, Longo G, Narni F, Barozzi P, et al. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia. 10:1996;351-355.
50. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood. 87:1996;4296-4301.
51. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol. 67:1993;3923-3930.
52. Kato N, Nakazawa T, Ootsuyama Y, Sugiyama K, Ohkoshi S, Shimotohno K. Virus isolate-specific antibodies against hypervariable region 1 of the hepatitis C virus second envelope protein, gp70. Jpn J Cancer Res. 85:1994;987-991.
53. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science. 253:1991;71-74.
54. Takeuchi Y, Akutsu M, Murayama K, Shimizu N, Hoshino H. Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J Virol. 65:1991;1710-1718.
55. Shioda T, Oka S, Ida S, Nokihara K, Toriyoshi H, Mori S, et al. A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus. J Virol. 68:1994;7689-7696.
56. Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M, et al. Determinants in the 5′ noncoding region of poliovirus sabin 1 RNA that influence the attenuation phenotype. J Virol. 63:1989;1302-1309.
57. Day SP, Murphy P, Brown A, Lemon SM. Mutations within the 5′ nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J Virol. 66:1992;6533-6540.
58. Kojima M, Osuga T, Tsuda F, Tanaka T, Okamoto H. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selected replication of hepatitis C virus in chimpanzees. Virology. 204:1994;665-672.
59. Gretch DR, Polyak SJ, Wilson JJ, Carithers RL, Perkins JD, Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol. 70:1996;7622-7631.
60. Lawal Z, Petrik J, Wong VS, Alexander GJM, Alan JP. Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology. 228:1997;107-111.